GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT05335018 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05335018
- Sponsor
- Seoul National University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2025-11-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.